HIV
The assay runs on a novel isothermal molecular instrument designed for low-resource setting with unreliable electrical supplies.
Roche Cobas 5800, HIV-1 Assay Gets Premarket Approval from FDA
The compact, fully automated system will be commercially available in the fourth quarter of 2022, Roche said.
CRISPR Screens Identify Potential Host Targets to Reverse HIV-1 Latency
By combining the targeting of host genes with latency reversing agents, the researchers hope to reactivate latent HIV-1 to then enable drugs to kill the infected cells.
HIV Risk Reduced in Carriers of Allele Linked to Severe COVID-19
HIV infection risk was roughly 27 percent lower in individuals with a COVID-19 risk allele that reduced CCR5 chemokine receptor gene expression.
HIV Sequencing Study in Netherlands Uncovers Virulent Variant Mutations, History
Along with analyses focused on de novo mutations contributing to virulence and transmissibility, researchers traced the HIV-1 VB variant back to at least the early 1990s.
Jul 29, 2021
Cepheid Nabs CE Mark for PCR-Based HIV-1 Tests
May 7, 2020
Grifols ART System Nabs FDA Approval
May 6, 2020
OraSure Technologies Q1 Revenues Rise 5 Percent
Feb 19, 2020
OraSure Technologies Q4 Revenues Down 1 Percent
Jan 30, 2020